GLP-1 is a peptide hormone generated from proglucagon that is secreted after meals by enteroendocrine L-cells in the distal jejunum, ileum, and colon. GLP-1 is also produced by pancreatic α-cells and ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Medications best known for treating diabetes and supporting weight loss, such as Ozempic and Wegovy, may also change how the body experiences alcohol.

The word microdosing might make you think of LSD and magic mushrooms, but the term has gained a totally new meaning in the Age of Ozempic. Microdosing—essentially, taking a smaller dose of something ...

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

Risks for kidney failure and major cardiovascular events between three GLP-1 receptor agonists were similar among veterans with diabetes. Mortality risk and certain adverse events differed between the ...

Pharmaceutical vending machine at an airport. Image by Tim Sandle. Pharmaceutical vending machine at an airport. Image by Tim Sandle. Can a new discovery usher in a new generation of GLP-1 peptides – ...

If you live with obesity or type 2 diabetes, your doctor may have talked to you about GIP/GLP-1 agonist medications, such as tirzepatide (Mounjaro or Zepbound), which may help you lose weight. And ...

Natasha Bhuyan, MD, is a board-certified family physician at Amazon One Medical in Phoenix, AZ, and One Medical’s national medical director and vice president of in-office care. Dr. Bhuyan serves on ...

GLP-1RAs improved RA disease activity, pain scores, weight, cholesterol, and HbA1c levels in patients with a BMI ≥27. Nearly one-third of patients discontinued GLP-1RA therapy due to gastrointestinal ...